title: [Expression of bioinformatically identified genes in skin of psoriasis patients].
abstract: Gene expression analysis for EPHA2 (EPH receptor A2), EPHB2 (EPH receptor B2), S100A9 (S100 calcium binding protein A9), PBEF(nicotinamide phosphoribosyltransferase), LILRB2 (leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 2), PLAUR (plasminogen activator, urokinase receptor), LTB (lymphotoxin beta (TNF superfamily, member 3)), WNT5A (wingless-type MMTV integration site family, member 5A) has been conducted using real-time polymerase chain reaction in specimens affected by psoriasis versus visually intact skin in 18 patients. It was revealed that the expression of the nine examined genes was upregulated in the affected by psoriasis compared to visually intact skin specimens. The highest expression was observed for S100A9, S100AS, PBEF, WNT5A2, and EPHB2 genes. S100A9 and S100A8 gene expression in the affected by psoriasis skin was 100-fold higher versus visually intact skin while PBEF, WNT5A, and EPHB2 gene expression was upregulated more than five-fold. We suggested that the high expression of these genes might be associated with the state of the pathological process in psoriasis. Moreover, the transcriptional activity of these genes might serve a molecular indicator of the efficacy of treatment in psoriasis.
authors.forename: V V
authors.initials: VV
authors.lastname: Sobolev
authors.forename: T A
authors.initials: TA
authors.lastname: Nikol'skaia
authors.forename: A D
authors.initials: AD
authors.lastname: Zolotarenko
authors.forename: E S
authors.initials: ES
authors.lastname: Piruzian
authors.forename: S A
authors.initials: SA
authors.lastname: Bruskin
mesh_terms: D000328:Adult; D001706:Biopsy; D040501:Calgranulin A / Q000235:genetics; D040502:Calgranulin B / Q000235:genetics; D016207:Cytokines / Q000235:genetics; D005260:Female; D020869:Gene Expression Profiling / Q000379:methods*; D005786:Gene Expression Regulation; D005819:Genetic Markers; D006801:Humans; D008297:Male; D008875:Middle Aged; D054409:Nicotinamide Phosphoribosyltransferase / Q000235:genetics; D011518:Proto-Oncogene Proteins / Q000235:genetics; D011565:Psoriasis / Q000235:genetics* / Q000473:pathology; D036183:Receptor, EphB2 / Q000235:genetics; D012867:Skin / Q000473:pathology*; D051153:Wnt Proteins / Q000235:genetics; D000071818:Wnt-5a Protein
chemical_list: D040501:Calgranulin A; D040502:Calgranulin B; D016207:Cytokines; D005819:Genetic Markers; D011518:Proto-Oncogene Proteins; C085389:WNT5A protein, human; D051153:Wnt Proteins; D000071818:Wnt-5a Protein; D054409:Nicotinamide Phosphoribosyltransferase; C085455:nicotinamide phosphoribosyltransferase, human; C586310:EPHB2 protein, human; D036183:Receptor, EphB2